Skip to content

Clinical trials

Carcinoma, Ductal, Breast trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ductal, Breast Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20033
20043
20055
20078
20087
20094
20104
20112
20123
20137
20143
20151
20163
20175
20184
20195
20202
20212
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status12
Terminated9
Active, not recruiting6
Recruiting6
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center4
GBG Forschungs GmbH4
RenJi Hospital4
Alliance for Clinical Trials in Oncology3
Case Comprehensive Cancer Center3
Intarcia Therapeutics3
Eastern Cooperative Oncology Group2
G1 Therapeutics, Inc.2
Memorial Sloan Kettering Cancer Center2
NSABP Foundation Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ductal, Breast86
Breast Neoplasms65
Carcinoma, Lobular27
Carcinoma, Intraductal, Noninfiltrating21
Breast Carcinoma In Situ12
Inflammatory Breast Neoplasms11
Breast Neoplasms, Male6
Neoplasm Metastasis3
Neoplasms, Hormone-Dependent3
Triple Negative Breast Neoplasms3

Trials

Showing 76 to 86 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.